The mood stabilizers lithium and valproate disrupt hepatic and intestinal farnesoid X receptor signalling and increase bile synthesis in the rat

Documenti analoghi

• Targeting the Microbiota Reverses C‐Section‐Induced Effects on Intestinal Permeability, Microbiota Composition, and Amygdala Gene Expression in the Mouse
  di: Ana Paula Ventura Silva, et al.
  Pubblicazione: (2025)
• Oleanolic acid induces hepatic injury by disrupting hepatocyte tight junction and dysregulation of farnesoid X receptor‐mediated bile acid efflux transporters
  di: Li Zeng, et al.
  Pubblicazione: (2024)
• Nano‐plastics disrupt systemic metabolism by remodeling the bile acid–microbiota axis and driving hepatic–intestinal dysfunction
  di: Yi Zhang, et al.
  Pubblicazione: (2025)
• Cyanidin‐3‐O‐glucoside magic: Unveiling the power to inhibit cholesterol absorption via the intestinal farnesoid X receptor–bile acids pathway with Lactobacillus Marvel
  di: Sihang Wang, et al.
  Pubblicazione: (2024)
• Clinical dilemma of mood stabilizer augmentation in treatment‐resistant schizophrenia with residual phase: A case report of valproate‐associated hypoglycemia and cytopenia, and subsequent lithium response
  di: Yoshiki Kasagi, et al.
  Pubblicazione: (2026)